The Make America Healthy Again movement had a negative impact on pharmaceutical innovation and the corporations responsible for it.
AstraZeneca will gain full rights for roxadustat in China where it is approved to treat anaemia seen with chronic kidney ...
The FTSE 100 closed down 54.20 points at 8712.53. Among the companies with reports and trading updates today are HSBC, BAE ...
Judging from its top line, AstraZeneca had a stellar 2024, generating an 18% increase in revenue, with 14 of the products in ...
Astrazeneca has defended the £14.7 million pay package handed to chief executive Pascal Soriot, saying the group is too big ...
Pascal Soriot (pictured) topped up his basic salary of £1.8m with extras that included a bonus of £3.5m and share awards ...
Astrazeneca is too big and complex to base its chief executive’s pay packet on the rest of the FTSE index, according to the ...
The Cambridge-based pharmaceutical company behind a variety of medicines paid its chief executive Pascal Soriot £14.7 million in 2024.
Wearing a “Tech Support”-printed T-shirt, Elon Musk virtually took to the stage on the final day of the World Governments ...
Hosted on MSN13d
Peer demands answers on AstraZeneca deal collapsePascal Soriot, chief executive of AstraZeneca, said there was no rift with the government but the deal was no longer ...
After the election, the new Labour government claimed there had been no due diligence done on the deal and it offered a ...
Access to eight fresh articles a day, hand-picked by senior editors. Selected to feed your curiosity. Complete digital access to quality FT journalism with expert analysis from industry leaders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results